Transplant Library

Multicenter randomized trial of HCV treatment with peginterferon-alfa2a and ribavirin after liver transplantation: 18-month report [abstract]

Calmus Y
Samuel D
Pageaux G
Boudjema K
Messner M
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):1060-1.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Prospective analysis of functional foxp3+cd4+cd25bright+ regulatory T-cells in anti-cd25 treated kidney transplant recipients [abstract]

Baan C
Klepper M
Ijzermans J
Weimar W

Transplantation. 2020 Jul;82(1 Suppl 3):1055-6.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

A prospective randomized trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: hematologic complications [abstract]

Farney A
Sundberg A
Moore P
Rogers J
Hartmann E
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):867.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications [abstract]

Farney A
Sundberg A
Moore P
Hartmann E
Rogers J
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):866-7.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Maintained efficiacy with steroid minimization in pediatric liver transplant recipients with basiliximab (simulect) induction therapy: a german multicenter randomized 12-month trial [abstract]

Ganschow R
Melter M
Wallot M
Schulz A
Pfister E
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):856.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Randomized placebo controlled study on the effects of losartan and carvedilol on oxidative stress in renal transplant recipients [abstract]

Renke M
Tylicki L
Biedunkiewicz B
Chamienia A
Wojnaroski K
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):814.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Randomised controlled trial of open versus laparoscopic live donor nephrectomy [abstract]

Nicholson M
Brook N
Elwell R
Veitch P
Kaushik M
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):798.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Five-year results of a prospective randomized controlled trial of six-months of mycophenolate mofetil in de novo renal transplant recipients on cyclosporin based immunosuppression [abstract]

Lou H
Vathsala A

Transplantation. 2020 Jul;82(1 Suppl 3):656.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Everolimus (Ev) versus azathioprine (Az) in a cyclosporine (Cy) and ketoconazole (K) based immunosuppressive therapy in kidney transplantation: an open-label, prospective, cohort, comparative clinical trial [abstract]

Gonzalez F
Herrara P
Espinoza M
Rocca X
Reynolds E
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):508-9.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus - a randomized controlled trial [abstract]

Meier M
Martin M
Wolfram J
Waichi W
Juergen S
et al.

Transplantation. 2020 Jul;82(1 Suppl 3):502.

World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts

Ovid Technologies, Inc.

Select article 'Multicenter randomized trial of HCV treatment with peginterferon-alfa2a and ribavirin after liver transplantation: 18-month report [abstract]'	Multicenter randomized trial of HCV treatment with peginterferon-alfa2a and ribavirin after liver transplantation: 18-month report [abstract] Calmus Y Samuel D Pageaux G Boudjema K Messner M et al. Transplantation. 2020 Jul;82(1 Suppl 3):1060-1. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Prospective analysis of functional foxp3+cd4+cd25bright+ regulatory T-cells in anti-cd25 treated kidney transplant recipients [abstract]'	Prospective analysis of functional foxp3+cd4+cd25bright+ regulatory T-cells in anti-cd25 treated kidney transplant recipients [abstract] Baan C Klepper M Ijzermans J Weimar W Transplantation. 2020 Jul;82(1 Suppl 3):1055-6. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'A prospective randomized trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: hematologic complications [abstract]'	A prospective randomized trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: hematologic complications [abstract] Farney A Sundberg A Moore P Rogers J Hartmann E et al. Transplantation. 2020 Jul;82(1 Suppl 3):867. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications [abstract]'	A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications [abstract] Farney A Sundberg A Moore P Hartmann E Rogers J et al. Transplantation. 2020 Jul;82(1 Suppl 3):866-7. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Maintained efficiacy with steroid minimization in pediatric liver transplant recipients with basiliximab (simulect) induction therapy: a german multicenter randomized 12-month trial [abstract]'	Maintained efficiacy with steroid minimization in pediatric liver transplant recipients with basiliximab (simulect) induction therapy: a german multicenter randomized 12-month trial [abstract] Ganschow R Melter M Wallot M Schulz A Pfister E et al. Transplantation. 2020 Jul;82(1 Suppl 3):856. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Randomized placebo controlled study on the effects of losartan and carvedilol on oxidative stress in renal transplant recipients [abstract]'	Randomized placebo controlled study on the effects of losartan and carvedilol on oxidative stress in renal transplant recipients [abstract] Renke M Tylicki L Biedunkiewicz B Chamienia A Wojnaroski K et al. Transplantation. 2020 Jul;82(1 Suppl 3):814. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Randomised controlled trial of open versus laparoscopic live donor nephrectomy [abstract]'	Randomised controlled trial of open versus laparoscopic live donor nephrectomy [abstract] Nicholson M Brook N Elwell R Veitch P Kaushik M et al. Transplantation. 2020 Jul;82(1 Suppl 3):798. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Five-year results of a prospective randomized controlled trial of six-months of mycophenolate mofetil in de novo renal transplant recipients on cyclosporin based immunosuppression [abstract]'	Five-year results of a prospective randomized controlled trial of six-months of mycophenolate mofetil in de novo renal transplant recipients on cyclosporin based immunosuppression [abstract] Lou H Vathsala A Transplantation. 2020 Jul;82(1 Suppl 3):656. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Everolimus (Ev) versus azathioprine (Az) in a cyclosporine (Cy) and ketoconazole (K) based immunosuppressive therapy in kidney transplantation: an open-label, prospective, cohort, comparative clinical trial [abstract]'	Everolimus (Ev) versus azathioprine (Az) in a cyclosporine (Cy) and ketoconazole (K) based immunosuppressive therapy in kidney transplantation: an open-label, prospective, cohort, comparative clinical trial [abstract] Gonzalez F Herrara P Espinoza M Rocca X Reynolds E et al. Transplantation. 2020 Jul;82(1 Suppl 3):508-9. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.
Select article 'Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus - a randomized controlled trial [abstract]'	Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus - a randomized controlled trial [abstract] Meier M Martin M Wolfram J Waichi W Juergen S et al. Transplantation. 2020 Jul;82(1 Suppl 3):502. World Transplant Congress. The first joint international transplant meeting July 22-27, 2006, Boston, Massachusetts Ovid Technologies, Inc.

4,870 results

Filters • 1

4,870 results